Alzheimer's disease and vascular deficiency: Lessons from imaging studies and down syndrome

Current Gerontology and Geriatrics Research

Volumn 2012, Issue , 2012, Pages

  Reed Cossairt, Arlene ^a   Zhu, Xiongwei ^b   Lee, Hyoung Gon ^b   Reed, Charles ^c   Perry, George ^d   Petersen, Robert B ^b,e  

^a BOISE STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Southwest District Health ^*  (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863238901     PISSN: 16877063     EISSN: 16877071     Source Type: Journal    
DOI: 10.1155/2012/929734     Document Type: Review

References (28)

1. Alvarez N., Alzheimer disease in Down syndrome. Medscape Reference: Drugs, Diseases Procedures, September 2011, http://emedicine.medscape.com/ article/1136117-overview
2. Querfurth H. W., LaFerla F. M., Alzheimer's disease The New England Journal of Medicine 2010 362 4 329 344
3. Chaoui R., Prenatal ultrasound diagnosis of Down syndrome. After major malformations, soft markers, nuchal translucency and skeletal signs, a new vascular sign? Ultrasound in Obstetrics and Gynecology 2005 26 3 214 217 (Pubitemid 41545816)
4. Vila-Herrero E., Padilla-Parrado F., Vega-Pérez J., Garca-Casares N., Heras-Pérez J. A., Romero-Acebal M., Moya-moya syndrome and arterial dysplasia associated to Down syndrome Revista de Neurologia 2004 39 10 943 945 (Pubitemid 39643538)
5. Salmina A. B., Inzhutova A. I., Malinovskaya N. A., Petrova M. M., Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control Journal of Alzheimer's Disease 2010 22 1 17 36
6. Costa V., Sommese L., Casamassimi A., Colicchio R., Angelini C., Marchesano V., Milone L., Farzati B., Giovane A., Fiorito C., Rienzo M., Picardi M., Avallone B., Marco Corsi M., Sarubbi B., Calabr R., Salvatore P., Ciccodicola A., Napoli C., Impairment of circulating endothelial progenitors in Down syndrome BMC Medical Genomics 2010 3, article 40
7. Nunomura A., Perry G., Pappolla M. A., Friedland R. P., Hirai K., Chiba S., Smith M. A., Neuronal oxidative stress precedes amyloid- deposition in down syndrome Journal of Neuropathology and Experimental Neurology 2000 59 11 1011 1017
8. Lesniewski L. A., Connell M. L., Durrant J. R., Folian B. J., Anderson M. C., Donato A. J., Seals D. R., B6D2F1 mice are a suitable model of oxidative stress-mediated impaired endothelium-dependent dilation with aging Journals of Gerontology A 2009 64 1 9 20
9. Humpel C., Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? Experimental Gerontology 2011 46 4 225 232
10. Pogribna M., Melnyk S., Pogribny I., Chango A., Yi P., James S. J., Homocysteine metabolism in children with down syndrome: in vitro modulation The American Journal of Human Genetics 2001 69 1 88 95 (Pubitemid 32614021)
11. Fonseca C. T., Amaral D. M., Ribeiro M. G., Beserra I. C. R., Guimares M. M., Insulin resistance in adolescents with Down syndrome: a cross-sectional study BMC Endocrine Disorders 2005 5, article 6
12. Kerins G., Petrovic K., Bruder M. B., Gruman C., Medical conditions and medication use in adults with Down syndrome: a descriptive analysis Down Syndrome Research and Practice 2008 12 2 141 147
13. Blacker D., Tanzi R. E., The genetics of Alzheimer disease: current status and future prospects Archives of Neurology 1998 55 3 294 296 (Pubitemid 28146192)
14. Granic A., Padmanabhan J., Norden M., Potter H., Alzheimer A peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP Molecular Biology of the Cell 2010 21 4 511 520
15. Gold B. T., Powell D. K., Andersen A. H., Smith C. D., Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease NeuroImage 2010 52 4 1487 1494
16. Sanz-Arigita E. J., Schoonheim M. M., Damoiseaux J. S., Rombouts S. A. R. B., Maris E., Barkhof F., Scheltens P., Stam C. J., Loss of small-world networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity PLoS One 2010 5 11
17. Mawuenyega K. G., Sigurdson W., Ovod V., Munsell L., Kasten T., Morris J. C., Yarasheski K. E., Bateman R. J., Decreased clearance of CNS -amyloid in Alzheimer's disease Science 2010 330 6012 1774
18. Rosenberg G. A., Kyner W. T., Estrada E., Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions American Journal of Physiology 1980 238 1 F42 F49
19. Ott B. R., Cohen R. A., Gongvatana A., Okonkwo O. C., Johanson C. E., Stopa E. G., Donahue J. E., Silverberg G. D., Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease Journal of Alzheimer's Disease 2010 20 2 647 657
20. Wostyn P., Van Dam D., Audenaert K., De Deyn P. P., Increased cerebrospinal fluid production as a possible mechanism underlying caffeine's protective effect against Alzheimer's disease International Journal of Alzheimer's Disease 2011 2011 6
21. Johnson K. S., Sexton D. J., Cerebrospinal fluid: physiology and utility of an examination in disease states. April 2011, http://www.uptodate.com/ contents/cerebrospinal-fluid-physiology-and-utility-of-an-examination-in- disease-states
22. Hsu H.-Y., Jugular venous reflux and neurological disorders Acta Neurologica Taiwanica 2011 20 1 1 3
23. Chung C. P., Lin Y. J., Chao A. C., Lin S. J., Chen Y. Y., Wang Y. J., Hu H. H., Jugular venous hemodynamic changes with aging Ultrasound in Medicine and Biology 2010 36 11 1776 1782
24. Chung C.-P., Wang P.-N., Wu Y.-H., Tsao Y.-C., Sheng W.-Y., Lin K.-N., Lin S.-J., Hu H.-H., More severe white matter changes in the elderly with jugular venous reflux Annals of Neurology 2011 69 3 553 559
25. Gyure K. A., Durham R., Stewart W. F., Smialek J. E., Troncoso J. C., Intraneuronal A -amyloid precedes development of amyloid plaques in Down syndrome Archives of Pathology and Laboratory Medicine 2001 125 4 489 492 (Pubitemid 32291552)
26. Wolvetang E. W., Bradfield O. M., Tymms M., Zavarsek S., Hatzistavrou T., Kola I., Hertzog P. J., The chromosome 21 transcription factor ETS2 transactivates the -APP promoter: implications for Down syndrome Biochimica et Biophysica Acta 2003 1628 2 105 110 (Pubitemid 37288895)
27. Choi J. H., Berger J. D., Mazzella M. J., Morales-Corraliza J., Cataldo A. M., Nixon R. A., Ginsberg S. D., Levy E., Mathews P. M., Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model Journal of Neurochemistry 2009 110 6 1818 1827
28. Wiseman F. K., Alford K. A., Tybulewicz V. L. J., Fisher E. M. C., Down syndromerecent progress and future prospects Human Molecular Genetics 2009 18 1 R75 R83